BioCentury
ARTICLE | Finance

Drug delivery companies

February 21, 1995 8:00 AM UTC

Despite last week's FDA advisory committee recommendation for Liposome Technology Inc.'s DOX-SL liposomal doxorubicin (see BioCentury Extra, Feb. 15), the market value of the drug delivery group of ...